<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Orthop Surg Res</journal-id><journal-id journal-id-type="iso-abbrev">J Orthop Surg Res</journal-id><journal-title-group><journal-title>Journal of Orthopaedic Surgery and Research</journal-title></journal-title-group><issn pub-type="epub">1749-799X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6390312</article-id><article-id pub-id-type="publisher-id">1095</article-id><article-id pub-id-type="doi">10.1186/s13018-019-1095-z</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Direct anterior versus lateral approaches for clinical outcomes after total hip arthroplasty: a meta-analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Zhao</given-names></name><address><email>wangzhao321521@qq.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Bao</surname><given-names>Hong-wei</given-names></name><address><email>baohongweigkdr@163.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hou</surname><given-names>Jing-zhao</given-names></name><address><email>3365278929@qq.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Department of Orthopaedics, Jingjiang People&#x02019;s Hospital, 28 No, Zhongzhou Road, Jingjiang, Taizhou City, 214500 Jiangsu Province China </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>2</month><year>2019</year></pub-date><pub-date pub-type="pmc-release"><day>26</day><month>2</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>14</volume><elocation-id>63</elocation-id><history><date date-type="received"><day>9</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>5</day><month>2</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2019</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Objective</title><p id="Par1">To compare the outcomes of the direct anterior approach (DAA) with the lateral approach (LA) for total hip arthroplasty (THA) patients.</p></sec><sec><title>Methods</title><p id="Par2">Three English databases, PubMed, Embase, and the Cochrane Library, were searched for randomized controlled trials (RCTs) comparing the DAA with LA for THA. Information on the country, sample size, intervention, outcomes, and follow-up were extracted. Meta-analysis was performed using Stata 12.0.</p></sec><sec><title>Results</title><p id="Par3">Five RCTs totaling 475 patients (DAA&#x02009;=&#x02009;236, LA&#x02009;=&#x02009;239) were included in this meta-analysis. Compared with the LA, the DAA was associated with a reduction in the VAS at 6&#x02009;weeks (weighted mean difference (WMD)&#x02009;=&#x02009;&#x02212;&#x02009;0.41, 95% confidence interval (CI) &#x02212;&#x02009;0.63 to &#x02212;&#x02009;0.19, <italic>P</italic>&#x02009;=&#x02009;0.000) and total blood loss for THA patients (WMD&#x02009;=&#x02009;&#x02212;&#x02009;45.73, 95% CI &#x02212;&#x02009;84.72 to &#x02212;&#x02009;6.02, <italic>P</italic>&#x02009;=&#x02009;0.024). Moreover, the DAA was associated with an increase in walking velocity (WMD&#x02009;=&#x02009;5.01, 95% CI 2.32 to 7.70, <italic>P</italic>&#x02009;=&#x02009;0.000), stride length (WMD&#x02009;=&#x02009;3.12, 95% CI 2.42 to 3.82, <italic>P</italic>&#x02009;=&#x02009;0.000), and step length (WMD&#x02009;=&#x02009;4.09, 95% CI 1.03 to 7.14, <italic>P</italic>&#x02009;=&#x02009;0.009) compared with the LA group. There was no significant difference between groups in the Harris hip score, operation time, transfusion rate, length of hospital stay, and the occurrence of complications.</p></sec><sec><title>Conclusion</title><p id="Par4">Current evidence demonstrated a trend showing that the DAA had a better effect on pain relief and blood-saving effects for THA patients. However, considering the number and sample size of the included trials, more large-scale RCTs with high quality are needed to confirm our conclusion.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Anterior approach</kwd><kwd>Lateral approach</kwd><kwd>Total hip arthroplasty</kwd><kwd>Meta-analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2019</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par15">Total hip arthroplasty (THA) is generally considered one of the most successful orthopedic surgical procedures for relieving pain, restoring hip function, and improving quality of life in patients with osteoarthritis (OA) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Enhancement in THA has led to faster functional recovery, shorter length of hospital stay, and higher patient satisfaction [<xref ref-type="bibr" rid="CR3">3</xref>]. Among these factors, different surgical approaches can also affect the clinical outcomes after THA [<xref ref-type="bibr" rid="CR4">4</xref>]. The lateral approach (LA) is the preferred procedure of approximately 42% of orthopedic surgeons worldwide [<xref ref-type="bibr" rid="CR5">5</xref>]. However, the lateral approach requires muscle splitting, and thus, the postoperative pain is more severe [<xref ref-type="bibr" rid="CR6">6</xref>].</p><p id="Par16">The direct anterior approach (DAA) is an alternative surgical approach for THA. The DAA is less commonly used, although it is gaining popularity in recent years [<xref ref-type="bibr" rid="CR7">7</xref>]. Advocates of the DAA suggested that the DAA is an intermuscular and internervous approach with less muscle and soft-tissue dissection [<xref ref-type="bibr" rid="CR8">8</xref>]. Conversely, surgeons who favor the LA cite advantages of extensile exposure with low rates of postoperative instability [<xref ref-type="bibr" rid="CR9">9</xref>]. Several randomized controlled trials (RCTs) have compared the DAA to the lateral approach for THA. Many of these studies contained relatively small samples and demonstrated inconsistent outcomes [<xref ref-type="bibr" rid="CR7">7</xref>]. This uncertainty leaves the determination of which surgical approach to adopt to the preference of the surgeons. Mjaaland et al. [<xref ref-type="bibr" rid="CR10">10</xref>] reported that the DAA caused less pain but higher postoperative levels of creatine kinase.</p><p id="Par17">Two meta-analyses were recently published on this topic. Yue et al. [<xref ref-type="bibr" rid="CR11">11</xref>] conducted a meta-analysis and their final conclusion was that there is a lack of sufficient evidence to conclude whether the DAA or lateral approach is superior for THA patients. In this meta-analysis, the authors included non-RCTs and did not perform subgroup analysis. Therefore, there was a large heterogeneity in their meta-analysis. Putananon et al. [<xref ref-type="bibr" rid="CR12">12</xref>] conducted a network meta-analysis that compared the DAA, lateral, posterior, and posterior-2 approaches in THA. The results showed that the DAA and lateral approach ranked first and second, respectively, for THA. Network meta-analysis is an indirect analysis, and the evidence level was less than for direct meta-analysis.</p><p id="Par18">Several more recent RCTs on this subject have been published without conclusive results. Thus, we undertook a further meta-analysis to evaluate whether the DAA is superior to the LA with respect to (1) Harris hip score; (2) pain score at 2&#x02009;weeks, 6&#x02009;weeks, and 12&#x02009;weeks; (3) operation outcomes; and (4) complications and gait characteristics (velocity, stride length, and step length). We hypothesized that the DAA results in lower pain scores and less blood loss without increasing complications.</p></sec><sec id="Sec2"><title>Material and methods</title><p id="Par19">The systematic review and meta-analysis was in accordance with the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [<xref ref-type="bibr" rid="CR13">13</xref>] and AMSTAR (Assessing the methodological quality of systematic reviews) Guidelines.</p><sec id="Sec3"><title>Literature search</title><p id="Par20">Three English databases, PubMed, Embase, and the Cochrane Library, were searched from inception to October 10, 2018, with the following search terms: &#x0201c;direct anterior approach&#x0201d; OR &#x0201c;anterior&#x0201d; OR &#x0201c;direct anterior&#x0201d; AND &#x0201c;lateral approach&#x0201d; OR &#x0201c;lateral&#x0201d; AND &#x0201c;total hip arthroplasty&#x0201d; OR &#x0201c;total hip replacement&#x0201d; OR &#x0201c;THA&#x0201d; OR &#x0201c;THR&#x0201d; OR &#x0201c;&#x0201c;Arthroplasty, Replacement, Hip &#x0201d;[Mesh]&#x0201d;. There was no language or publication date restriction. We also searched reference lists of included trials and related meta-analyses to identify potentially omitted studies.</p></sec><sec id="Sec4"><title>Inclusion criteria</title><p id="Par21">
<list list-type="order"><list-item><p id="Par22">Participants: patients suffered from osteoarthritis and femur head necrosis and prepared for primary THA</p></list-item><list-item><p id="Par23">Interventions: the intervention group received the DAA for THA</p></list-item><list-item><p id="Par24">Comparisons: the control group received LA for THA</p></list-item><list-item><p id="Par25">Outcomes: Harris hip score at final follow-up; VAS at 2&#x02009;weeks, 6&#x02009;weeks, and 12&#x02009;weeks; operation time; total blood loss; transfusion rate; length of hospital stay; complications; and temporal and spatial gait characteristics (velocity, stride length, and step length). Included studies should include at least one of the above outcomes.</p></list-item><list-item><p id="Par26">Study design: RCTs were regarded as eligible for the study</p></list-item></list>
</p></sec><sec id="Sec5"><title>Study selection</title><p id="Par27">Study selection was conducted by two reviewers. We removed the duplicates using Endnote X7 software (Thompson Reuters, CA, USA). According to the inclusion and exclusion criteria, we selected the included studies and downloaded the full text for data extraction. Discrepancies were reconciled through discussion or consultation with the author.</p></sec><sec id="Sec6"><title>Data extraction</title><p id="Par28">Data in the included trials were extracted by two independent investigators. Disagreement between the two reviewers was settled by discussion and consultation with a third reviewer. The extracted information included (1) the basic characteristics of the included studies, including the authors, publication year, no. in the DAA and LA groups, mean age, female patients, BMI; (2) outcomes (Harris hip score at final follow-up; VAS at 2&#x02009;weeks, 6&#x02009;weeks, and 12&#x02009;weeks; operation time, total blood loss, transfusion rate, length of hospital stay, and complications.); and (3) follow-up.</p></sec><sec id="Sec7"><title>Assessment of methodological quality</title><p id="Par29">Two authors assessed the quality of included studies independently with the risk-of-bias assessment tool outlined in the Cochrane Handbook. Seven domains were evaluated: (1) random sequence generation, (2) allocation concealment, (3) blinding of patients and personal information, (4) blinding of outcome assessment, (5) incomplete outcome data, (6) selective reporting of risk, and (7) other biases.</p></sec><sec id="Sec8"><title>Statistical analysis</title><p id="Par30">Stata 12.0 (Stata Corp., College Station, TX) was used for statistical analysis, and a <italic>P</italic> value&#x02009;&#x0003c;&#x02009;0.05 was considered statistically significant. The risk ratio (RR) with 95% confidence intervals (CI) for the DAA compared with the LA was calculated for the transfusion rate and the occurrence of complications. Weighted mean differences (WMD) and 95% CI were calculated for continuous variables. A fixed effects model was chosen when there was no statistical evidence of heterogeneity (<italic>I</italic><sup>2</sup>&#x000a0;&#x0003c;&#x02009;50%), and a random effects model was adopted if significant heterogeneity was found (<italic>I</italic><sup>2</sup>&#x000a0;&#x02265;&#x02009;50%). In addition, publication bias was assessed by funnel plots.</p></sec></sec><sec id="Sec9"><title>Results</title><sec id="Sec10"><title>Study characteristics</title><p id="Par31">The process of study selection is shown in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. Initially, we identified 205 records through database searching. After removing duplicates, only 158 papers remained for the next step. According to the inclusion criteria, 153 records were excluded. Finally, a total of 5 RCTs [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR17">17</xref>] met the inclusion criteria and were included in this meta-analysis.<fig id="Fig1"><label>Fig. 1</label><caption><p>The flow diagram of study selection</p></caption><graphic xlink:href="13018_2019_1095_Fig1_HTML" id="MO1"/></fig></p><p id="Par32">Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> displays the detailed general characteristics of the included studies. A total of 475 patients were available for meta-analysis. The five eligible RCTs involved 236 hips that underwent the DAA and 239 hips that underwent the LA. All papers were published from 2009 to 2018. The sample size ranged from 16 to 84. The follow-up duration ranged from 3&#x02009;to 48&#x02009;months.<table-wrap id="Tab1"><label>Table 1</label><caption><p>General characteristic of the included studies. 1, Harris hip score at final follow-up; 2, VAS at 2&#x02009;weeks, 6&#x02009;weeks, and 12&#x02009;weeks; 3, operation time, 4, total blood loss, 5, transfusion rate, 6, length of hospital stay, 7, complications, 8, temporal and spatial gait characteristics (velocity, stride length, and step length)</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Author</th><th>Country</th><th>No. of patients (<italic>n</italic>)</th><th>Mean age (years)</th><th>Female (%)</th><th>BMI (kg/m<sup>2</sup>)</th><th>Outcomes</th><th>Study</th><th>Follow-up</th></tr></thead><tbody><tr><td>Mjaaland 2015</td><td>Norway</td><td>84/80</td><td>66.9</td><td>66</td><td>27.65</td><td>1, 2, 3, 5, 7, 8</td><td>RCT</td><td>At discharge</td></tr><tr><td>Restrepo 2010</td><td>USA</td><td>50/50</td><td>67.2</td><td>69.8</td><td>27.6</td><td>1, 3, 4, 6, 9</td><td>RCT</td><td>48&#x02009;months</td></tr><tr><td>Parvizi 2016</td><td>USA</td><td>50/50</td><td>72.4</td><td>62</td><td>28</td><td>1, 2, 5, 7, 8</td><td>RCT</td><td>12&#x02009;months</td></tr><tr><td>Mayr 2009</td><td>Austria</td><td>16/17</td><td>66</td><td>52.5</td><td>25.6</td><td>2, 3, 4, 5, 9</td><td>RCT</td><td>3&#x02009;months</td></tr><tr><td>Zomar 2018</td><td>Canada</td><td>36/42</td><td>60.2</td><td>52</td><td>27.9</td><td>1, 2, 3, 4, 5</td><td>RCT</td><td>3&#x02009;months</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec11"><title>Risk of bias</title><p id="Par33">The risk-of-bias summary and risk-of-bias graph are displayed in Figs.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>, respectively. The random sequence generation was described fairly well in four studies, and allocation concealment was described in three studies. In the remainder, this information was absent or unclear. Attrition bias, reporting bias, and other biases were all described fairly well and listed as a low risk of bias.<fig id="Fig2"><label>Fig. 2</label><caption><p>Risk of bias summary for included studies. +, no bias; &#x02212;, bias;?, bias unknown</p></caption><graphic xlink:href="13018_2019_1095_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Risk of bias graph: review authors&#x02019; judgments about each risk of bias item presented as percentages across all included studies</p></caption><graphic xlink:href="13018_2019_1095_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec12"><title>Primary outcomes</title><sec id="Sec13"><title>Harris hip score at final follow-up</title><p id="Par34">A total of three studies totaling 342 THAs (DAA&#x02009;=&#x02009;170, LA&#x02009;=&#x02009;172) reported Harris hip scores at the final follow-up. There was no significant difference between the DAA and LA groups in terms of the Harris hip score at final follow-up (WMD&#x02009;=&#x02009;0.63, 95% CI&#x02009;=&#x02009;&#x02212;&#x02009;2.54, 3.71, <italic>P</italic>&#x02009;=&#x02009;0.689, Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). There was a large heterogeneity between the included studies (<italic>I</italic><sup>2</sup>&#x000a0;=&#x02009;98.1%); thus, we adopted a random effects model to pool the relevant data. Funnel plot analyses on the Harris hip score demonstrated symmetry, suggesting that bias was minimal (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Figure&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref> presents the results of sensitivity analyses. The findings for the Harris hip score were consistent after omitting each study in turn.<fig id="Fig4"><label>Fig. 4</label><caption><p>Forest plot for comparing the DAA versus LA in terms of Harris hip score at final follow-up</p></caption><graphic xlink:href="13018_2019_1095_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>Funnel plot for comparing the DAA versus LA in terms of Harris hip score at final follow-up</p></caption><graphic xlink:href="13018_2019_1095_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>Sensitivity analysis of Harris hip score at final follow-up</p></caption><graphic xlink:href="13018_2019_1095_Fig6_HTML" id="MO6"/></fig></p></sec><sec id="Sec14"><title>VAS at 2&#x02009;weeks, 6&#x02009;weeks, and 12&#x02009;weeks</title><p id="Par35">There was no significant difference between the DAA and LA groups in terms of the VAS at 2&#x02009;weeks (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.00, 95% CI &#x02212;&#x02009;0.16 to 0.15, <italic>P</italic>&#x02009;=&#x02009;0.966, Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>) and the VAS at 12&#x02009;weeks (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.13, 95% CI &#x02212;&#x02009;0.37 to 0.12, <italic>P</italic>&#x02009;=&#x02009;0.314, Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>). Compared with the LA, the DAA was associated with a reduction in the VAS at 6&#x02009;weeks (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.41, 95% CI &#x02212;&#x02009;0.63 to &#x02212;&#x02009;0.19, <italic>P</italic>&#x02009;=&#x02009;0.000, Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>).<fig id="Fig7"><label>Fig. 7</label><caption><p>Forest plot for comparing the DAA versus LA in terms of VAS at 2&#x02009;weeks, 6&#x02009;weeks, and 12&#x02009;weeks</p></caption><graphic xlink:href="13018_2019_1095_Fig7_HTML" id="MO7"/></fig></p></sec><sec id="Sec15"><title>Operation time</title><p id="Par36">Three trials totaling 364 patients provided data on operation time. There was no statistically significant difference between the DAA and LA groups in terms of the operation time (WMD&#x02009;=&#x02009;4.53, 95% CI &#x02212;&#x02009;6.60 to 15.65, <italic>P</italic>&#x02009;=&#x02009;0.425, Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>).<fig id="Fig8"><label>Fig. 8</label><caption><p>Forest plot for comparing the DAA versus LA in terms of operation time</p></caption><graphic xlink:href="13018_2019_1095_Fig8_HTML" id="MO8"/></fig></p></sec><sec id="Sec16"><title>Transfusion rate and total blood loss</title><p id="Par37">Three studies involving 364 patients provided data on the transfusion rate. Compared with the LA, the DAA had no benefit in reducing the transfusion rate after THA (RR&#x02009;=&#x02009;0.71, 95% CI 0.43 to 1.18, <italic>P</italic>&#x02009;=&#x02009;0.188, Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>).<fig id="Fig9"><label>Fig. 9</label><caption><p>Forest plot for comparing the DAA versus LA in terms of transfusion rate</p></caption><graphic xlink:href="13018_2019_1095_Fig9_HTML" id="MO9"/></fig></p><p id="Par38">Four trials totaling 397 patients provided data on total blood loss. Compared with the LA, the DAA reduced total blood loss in THA patients (WMD&#x02009;=&#x02009;&#x02212;&#x02009;45.73, 95% CI &#x02212;&#x02009;84.72 to &#x02212;&#x02009;6.02, <italic>P</italic>&#x02009;=&#x02009;0.024, Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>).<fig id="Fig10"><label>Fig. 10</label><caption><p>Forest plot for comparing the DAA versus LA in terms of total blood loss</p></caption><graphic xlink:href="13018_2019_1095_Fig10_HTML" id="MO10"/></fig></p></sec><sec id="Sec17"><title>Length of hospital stay</title><p id="Par39">Four trials totaling 442 patients provided data on the length of hospital stay. Compared with the LA, the DAA had no effect on reducing the length of hospital stay for THA patients (WMD&#x02009;=&#x02009;&#x02212;&#x02009;0.43, 95% CI &#x02212;&#x02009;1.06 to 0.20, <italic>P</italic>&#x02009;=&#x02009;0.179, Fig.&#x000a0;<xref rid="Fig11" ref-type="fig">11</xref>).<fig id="Fig11"><label>Fig. 11</label><caption><p>Forest plot for comparing the DAA versus LA in terms of length of hospital stay</p></caption><graphic xlink:href="13018_2019_1095_Fig11_HTML" id="MO11"/></fig></p></sec><sec id="Sec18"><title>Complications</title><p id="Par40">Five trials involving 475 patients provided data on complications. The results showed that there was no significant difference in complications between the DAA and LA groups (RR&#x02009;=&#x02009;0.94, 95% CI 0.57 to 1.55, <italic>P</italic>&#x02009;=&#x02009;0.820, Fig.&#x000a0;<xref rid="Fig12" ref-type="fig">12</xref>).<fig id="Fig12"><label>Fig. 12</label><caption><p>Forest plot for comparing the DAA versus LA in terms of the complications</p></caption><graphic xlink:href="13018_2019_1095_Fig12_HTML" id="MO12"/></fig></p></sec><sec id="Sec19"><title>Temporal and spatial gait characteristics</title><p id="Par41">Only two studies involving 111 patients provided data on temporal and spatial gait characteristics (velocity, stride length, and step length). Compared with the LA, the DAA was associated with an increase in walking velocity (WMD&#x02009;=&#x02009;5.01, 95% CI 2.32 to 7.70, <italic>P</italic>&#x02009;=&#x02009;0.000, Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>), stride length (WMD&#x02009;=&#x02009;3.12, 95% CI 2.42 to 3.82, <italic>P</italic>&#x02009;=&#x02009;0.000, Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>), and step length (WMD&#x02009;=&#x02009;4.09, 95% CI 1.03 to 7.14, <italic>P</italic>&#x02009;=&#x02009;0.009, Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>).<fig id="Fig13"><label>Fig. 13</label><caption><p>Forest plot for comparing the DAA versus LA in terms of the temporal and spatial gait characteristics (velocity, stride length, and step length)</p></caption><graphic xlink:href="13018_2019_1095_Fig13_HTML" id="MO13"/></fig></p></sec></sec></sec><sec id="Sec20"><title>Discussion</title><sec id="Sec21"><title>Main findings</title><p id="Par42">Our systematic review and meta-analysis comprehensively and systematically reviewed the current available literature and found that in THA patients, compared with the LA, (1) the DAA significantly reduced VAS at 6&#x02009;weeks and total blood loss; (2) the DAA significantly increased walking velocity, stride length, and step length in analyses of gait characteristics; and (3) the DAA had no benefit for Harris hip score, VAS at 2&#x02009;weeks and 12&#x02009;weeks, blood transfusion, length of hospital stay, and complications.</p></sec><sec id="Sec22"><title>Comparison with other meta-analyses</title><p id="Par43">Only two meta-analyses of the DAA versus LA for THA have been published. However, differences between ours and previous ones should be noted. First, previous meta-analyses included no more than two RCTs and 106 patients that compared DAA versus LA in THA patients [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In comparison, we included five RCTs totaling 475 patients. With the added statistical power of at least 369 patients, our current meta-analysis was the latest and the most comprehensive one. Yue et al. [<xref ref-type="bibr" rid="CR11">11</xref>] conducted a meta-analysis that compared the DAA and LA for THA. However, in this meta-analysis, they mixed RCTs and non-RCTs in the analyses. Thus, there was a large heterogeneity in their outcomes. Second, we applied further subgroup analysis and sensitivity analysis to provide a more credible estimate. Third, we compared gait characteristics between the DAA and LA.</p></sec><sec id="Sec23"><title>Implications for clinical practice</title><p id="Par44">Our meta-analysis showed that the DAA has a beneficial role in reducing postoperative pain and blood loss and increasing the function of hip joints. Therefore, the DAA might be the better approach for THA.</p><p id="Par45">Furthermore, operator experience and learning curve are equally important factors. All of the included studies have reported that the operators have surpassed the learning curves; thus, the current evidence is limited, and further trials are warranted to identify differences in the learning curve between the two approaches.</p><p id="Par46">First, we compared the Harris hip scores at the final follow-up. The results showed that the DAA and LA had similar hip function. Zomar et al. [<xref ref-type="bibr" rid="CR17">17</xref>] reported that there was no significant difference between the DAA and LA groups in terms of the patient-reported functional outcomes (<italic>P</italic>&#x02009;&#x0003e;&#x02009;0.05). However, Mirza et al. [<xref ref-type="bibr" rid="CR18">18</xref>] revealed that the DAA encourages earlier functional recovery than LA for THA patients. We found that the DAA only had a beneficial role in reducing VAS at 6&#x02009;weeks. Mjaaland et al. [<xref ref-type="bibr" rid="CR10">10</xref>] compared pain scores between the DAA and LA groups in THA patients. The results showed that there were lower pain scores in the DAA group on all recorded days. Zomar et al. [<xref ref-type="bibr" rid="CR17">17</xref>] found no differences in pain VAS at 2&#x02009;weeks and 12&#x02009;weeks postsurgery between the DAA and LA groups.</p><p id="Par47">Moreover, we found that the DAA was associated with a reduction in the total blood loss compared with the LA group. The DAA is an intermuscular and internervous approach without sacrificing muscle injury. Theoretically, the DAA could significantly reduce the approach-related blood loss. Tranexamic acid was routinely administered in THA, and thus, blood loss was not an important factor for hip function. Restrepo et al. [<xref ref-type="bibr" rid="CR14">14</xref>] estimated that blood loss was the same in the DAA and LA groups. We pooled total complications as the index for safety of these two approaches. The results showed that there was no significant difference between the groups in terms of complications.</p></sec><sec id="Sec24"><title>Strength of current meta-analysis</title><p id="Par48">A major strength of our meta-analysis was that we used gait characteristics (velocity, stride length, and step length) to analyze functional outcomes. The results showed that the DAA could increase walking velocity, stride length, and step length. All of the characteristics indicated that the DAA offers significant early advantages in functional recovery compared to the LA.</p></sec><sec id="Sec25"><title>Limitations</title><p id="Par49">Our meta-analysis also has several limitations: (1) only five studies (475 THAs) were included in our meta-analysis. The statistical efficacy of our results would be more reliable if more studies had been included. (2) Some studies included RCTs that lacked details of the allocation concealment and blinding methods, which may affect the quality of evidence and strength of the recommendations. (3) Follow-ups of these studies were relatively short (maximum follow-up&#x02009;=&#x02009;2&#x02009;years), and long-term follow-ups are needed to compare hip function between the DAA and LA. (4) There was substantial heterogeneity between the included outcomes. We performed subgroup analysis and sensitivity analysis to decrease the heterogeneity; however, the overall heterogeneity was not changed after subgroup analysis or after sensitivity analysis.</p></sec></sec><sec id="Sec26"><title>Conclusion</title><p id="Par50">In THA patients, compared with the LA, the DAA was associated with early functional recovery, low blood loss, and lower pain scores. There was no significant difference in Harris hip score or operation time between the DAA and LA groups. Considering the limitations of this meta-analysis, more high-quality RCTs are needed to further identify the effects of the DAA versus LA in THA patients.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CI</term><def><p id="Par5">Confidence intervals</p></def></def-item><def-item><term>DAA</term><def><p id="Par6">Direct anterior approach</p></def></def-item><def-item><term>LA</term><def><p id="Par7">Lateral approach</p></def></def-item><def-item><term>MeSH</term><def><p id="Par8">Medical Subject Headings</p></def></def-item><def-item><term>OA</term><def><p id="Par9">Osteoarthritis</p></def></def-item><def-item><term>PRISMA</term><def><p id="Par10">Preferred Reporting Items for Systematic Reviews and Meta-Analyses</p></def></def-item><def-item><term>RCTs</term><def><p id="Par11">Randomized controlled trials</p></def></def-item><def-item><term>RR</term><def><p id="Par12">Risk ratio</p></def></def-item><def-item><term>THA</term><def><p id="Par13">Total hip arthroplasty</p></def></def-item><def-item><term>WMD</term><def><p id="Par14">Weighted mean difference</p></def></def-item></def-list></glossary><ack><title>Acknowledgements</title><p>Not applicable.</p><sec id="FPar1"><title>Funding</title><p id="Par51">Not applicable.</p></sec><sec id="FPar2" sec-type="data-availability"><title>Availability of data and materials</title><p id="Par52">Supporting data are available.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>ZW designed the study and developed the retrieve strategy. HWB and JZH searched and screened the summaries and titles. ZW, HWB, and JZH drafted the article. All authors read and approved the final draft.</p></notes><notes notes-type="COI-statement"><sec id="FPar3"><title>Ethics approval and consent to participate</title><p>This is a meta-analysis; no relative problems exist.</p></sec><sec id="FPar4"><title>Consent for publication</title><p>Not applicable.</p></sec><sec id="FPar5"><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec id="FPar6"><title>Publisher&#x02019;s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hojer Karlsen</surname><given-names>AP</given-names></name><name><surname>Geisler</surname><given-names>A</given-names></name><name><surname>Petersen</surname><given-names>PL</given-names></name><name><surname>Mathiesen</surname><given-names>O</given-names></name><name><surname>Dahl</surname><given-names>JB</given-names></name></person-group><article-title>Postoperative pain treatment after total hip arthroplasty: a systematic review</article-title><source>Pain</source><year>2015</year><volume>156</volume><issue>1</issue><fpage>8</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1016/j.pain.0000000000000003</pub-id><pub-id pub-id-type="pmid">25599296</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marques</surname><given-names>EM</given-names></name><name><surname>Jones</surname><given-names>HE</given-names></name><name><surname>Elvers</surname><given-names>KT</given-names></name><name><surname>Pyke</surname><given-names>M</given-names></name><name><surname>Blom</surname><given-names>AW</given-names></name><name><surname>Beswick</surname><given-names>AD</given-names></name></person-group><article-title>Local anaesthetic infiltration for peri-operative pain control in total hip and knee replacement: systematic review and meta-analyses of short- and long-term effectiveness</article-title><source>BMC Musculoskelet Disord</source><year>2014</year><volume>15</volume><fpage>220</fpage><pub-id pub-id-type="doi">10.1186/1471-2474-15-220</pub-id><pub-id pub-id-type="pmid">24996539</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Karunaratne S, Duan M, Pappas E, Fritsch B, Boyle R, Gupta S, Stalley P, Horsley M, Steffens D. The effectiveness of robotic hip and knee arthroplasty on patient-reported outcomes: a systematic review and meta-analysis. Int Orthop. 2018; [Epub ahead of print].</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>ZD</given-names></name><name><surname>Orozco</surname><given-names>F</given-names></name><name><surname>Diaz-Ledezma</surname><given-names>C</given-names></name><name><surname>Hozack</surname><given-names>WJ</given-names></name><name><surname>Ong</surname><given-names>A</given-names></name></person-group><article-title>Direct anterior approach for total hip arthroplasty: indications, technique, and results</article-title><source>J Am Acad Orthop Surg</source><year>2014</year><volume>22</volume><issue>9</issue><fpage>595</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.5435/JAAOS-22-09-595</pub-id><pub-id pub-id-type="pmid">25157041</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chechik</surname><given-names>O</given-names></name><name><surname>Khashan</surname><given-names>M</given-names></name><name><surname>Lador</surname><given-names>R</given-names></name><name><surname>Salai</surname><given-names>M</given-names></name><name><surname>Amar</surname><given-names>E</given-names></name></person-group><article-title>Surgical approach and prosthesis fixation in hip arthroplasty world wide</article-title><source>Arch Orthop Trauma Surg</source><year>2013</year><volume>133</volume><issue>11</issue><fpage>1595</fpage><lpage>1600</lpage><pub-id pub-id-type="doi">10.1007/s00402-013-1828-0</pub-id><pub-id pub-id-type="pmid">23912418</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meermans</surname><given-names>G</given-names></name><name><surname>Konan</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>R</given-names></name><name><surname>Volpin</surname><given-names>A</given-names></name><name><surname>Haddad</surname><given-names>FS</given-names></name></person-group><article-title>The direct anterior approach in total hip arthroplasty: a systematic review of the literature</article-title><source>Bone Joint J</source><year>2017</year><volume>99-b</volume><issue>6</issue><fpage>732</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.99B6.38053</pub-id><pub-id pub-id-type="pmid">28566391</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graves</surname><given-names>SC</given-names></name><name><surname>Dropkin</surname><given-names>BM</given-names></name><name><surname>Keeney</surname><given-names>BJ</given-names></name><name><surname>Lurie</surname><given-names>JD</given-names></name><name><surname>Tomek</surname><given-names>IM</given-names></name></person-group><article-title>Does surgical approach affect patient-reported function after primary THA?</article-title><source>Clin Orthop Relat Res</source><year>2016</year><volume>474</volume><issue>4</issue><fpage>971</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.1007/s11999-015-4639-5</pub-id><pub-id pub-id-type="pmid">26620966</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petis</surname><given-names>SM</given-names></name><name><surname>Vasarhelyi</surname><given-names>EM</given-names></name><name><surname>Howard</surname><given-names>JL</given-names></name><name><surname>Lanting</surname><given-names>BA</given-names></name></person-group><article-title>Gait analysis following release of the short external rotators during an anterior approach for total hip arthroplasty</article-title><source>Hip Int</source><year>2018</year><volume>28</volume><issue>6</issue><fpage>584</fpage><lpage>590</lpage><pub-id pub-id-type="doi">10.1177/1120700017752514</pub-id><pub-id pub-id-type="pmid">30033777</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petis</surname><given-names>S</given-names></name><name><surname>Howard</surname><given-names>J</given-names></name><name><surname>Lanting</surname><given-names>B</given-names></name><name><surname>Jones</surname><given-names>I</given-names></name><name><surname>Birmingham</surname><given-names>T</given-names></name><name><surname>Vasarhelyi</surname><given-names>E</given-names></name></person-group><article-title>Comparing the anterior, posterior and lateral approach: gait analysis in total hip arthroplasty</article-title><source>Can J Surg Journal canadien de chirurgie</source><year>2018</year><volume>61</volume><issue>1</issue><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1503/cjs.003217</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mjaaland</surname><given-names>KE</given-names></name><name><surname>Kivle</surname><given-names>K</given-names></name><name><surname>Svenningsen</surname><given-names>S</given-names></name><name><surname>Pripp</surname><given-names>AH</given-names></name><name><surname>Nordsletten</surname><given-names>L</given-names></name></person-group><article-title>Comparison of markers for muscle damage, inflammation, and pain using minimally invasive direct anterior versus direct lateral approach in total hip arthroplasty: a prospective, randomized, controlled trial</article-title><source>J Orthop Res : official publication of the Orthopaedic Research Society</source><year>2015</year><volume>33</volume><issue>9</issue><fpage>1305</fpage><lpage>1310</lpage><pub-id pub-id-type="doi">10.1002/jor.22911</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>C</given-names></name><name><surname>Kang</surname><given-names>P</given-names></name><name><surname>Pei</surname><given-names>F</given-names></name></person-group><article-title>Comparison of direct anterior and lateral approaches in total hip arthroplasty: a systematic review and meta-analysis (PRISMA)</article-title><source>Medicine</source><year>2015</year><volume>94</volume><issue>50</issue><fpage>e2126</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000002126</pub-id><pub-id pub-id-type="pmid">26683920</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Putananon</surname><given-names>C</given-names></name><name><surname>Tuchinda</surname><given-names>H</given-names></name><name><surname>Arirachakaran</surname><given-names>A</given-names></name><name><surname>Wongsak</surname><given-names>S</given-names></name><name><surname>Narinsorasak</surname><given-names>T</given-names></name><name><surname>Kongtharvonskul</surname><given-names>J</given-names></name></person-group><article-title>Comparison of direct anterior, lateral, posterior and posterior-2 approaches in total hip arthroplasty: network meta-analysis</article-title><source>Eur J Orthop Surg Traumatol</source><year>2018</year><volume>28</volume><issue>2</issue><fpage>255</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1007/s00590-017-2046-1</pub-id><pub-id pub-id-type="pmid">28956180</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamseer</surname><given-names>L</given-names></name><name><surname>Moher</surname><given-names>D</given-names></name><name><surname>Clarke</surname><given-names>M</given-names></name><name><surname>Ghersi</surname><given-names>D</given-names></name><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Petticrew</surname><given-names>M</given-names></name><name><surname>Shekelle</surname><given-names>P</given-names></name><name><surname>Stewart</surname><given-names>LA</given-names></name></person-group><article-title>Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation</article-title><source>BMJ (Clinical research ed)</source><year>2015</year><volume>350</volume><fpage>g7647</fpage></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Restrepo</surname><given-names>C</given-names></name><name><surname>Parvizi</surname><given-names>J</given-names></name><name><surname>Pour</surname><given-names>AE</given-names></name><name><surname>Hozack</surname><given-names>WJ</given-names></name></person-group><article-title>Prospective randomized study of two surgical approaches for total hip arthroplasty</article-title><source>J Arthroplast</source><year>2010</year><volume>25</volume><issue>5</issue><fpage>671</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1016/j.arth.2010.02.002</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parvizi</surname><given-names>J</given-names></name><name><surname>Restrepo</surname><given-names>C</given-names></name><name><surname>Maltenfort</surname><given-names>MG</given-names></name></person-group><article-title>Total hip arthroplasty performed through direct anterior approach provides superior early outcome: results of a randomized, prospective study</article-title><source>Orthop Clin North Am</source><year>2016</year><volume>47</volume><issue>3</issue><fpage>497</fpage><lpage>504</lpage><pub-id pub-id-type="doi">10.1016/j.ocl.2016.03.003</pub-id><pub-id pub-id-type="pmid">27241374</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayr</surname><given-names>E</given-names></name><name><surname>Nogler</surname><given-names>M</given-names></name><name><surname>Benedetti</surname><given-names>MG</given-names></name><name><surname>Kessler</surname><given-names>O</given-names></name><name><surname>Reinthaler</surname><given-names>A</given-names></name><name><surname>Krismer</surname><given-names>M</given-names></name><name><surname>Leardini</surname><given-names>A</given-names></name></person-group><article-title>A prospective randomized assessment of earlier functional recovery in THA patients treated by minimally invasive direct anterior approach: a gait analysis study</article-title><source>Clin Biomech (Bristol, Avon)</source><year>2009</year><volume>24</volume><issue>10</issue><fpage>812</fpage><lpage>818</lpage><pub-id pub-id-type="doi">10.1016/j.clinbiomech.2009.07.010</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zomar</surname><given-names>BO</given-names></name><name><surname>Bryant</surname><given-names>D</given-names></name><name><surname>Hunter</surname><given-names>S</given-names></name><name><surname>Howard</surname><given-names>JL</given-names></name><name><surname>Vasarhelyi</surname><given-names>EM</given-names></name><name><surname>Lanting</surname><given-names>BA</given-names></name></person-group><article-title>A randomised trial comparing spatio-temporal gait parameters after total hip arthroplasty between the direct anterior and direct lateral surgical approaches</article-title><source>Hip Int : the journal of clinical and experimental research on hip pathology and therapy</source><year>2018</year><volume>28</volume><issue>5</issue><fpage>478</fpage><lpage>484</lpage><pub-id pub-id-type="doi">10.1177/1120700018760262</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mirza</surname><given-names>AJ</given-names></name><name><surname>Lombardi</surname><given-names>AV</given-names><suffix>Jr</suffix></name><name><surname>Morris</surname><given-names>MJ</given-names></name><name><surname>Berend</surname><given-names>KR</given-names></name></person-group><article-title>A mini-anterior approach to the hip for total joint replacement: optimising results: improving hip joint replacement outcomes</article-title><source>Bone Joint J</source><year>2014</year><volume>96-b</volume><issue>11 Supple A</issue><fpage>32</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1302/0301-620X.96B11.34348</pub-id><pub-id pub-id-type="pmid">25381405</pub-id></element-citation></ref></ref-list></back></article>